Literature DB >> 8783420

Immunohistochemical detection of factor XIIIa and factor XIIIs in synovial membranes of patients with rheumatoid arthritis or osteoarthritis.

A Plenz1, P Fritz, G König, W Laschner, J G Saal.   

Abstract

In spite of differences in etiology, RA and OA lead to astonishingly similar synovitic alterations. Fibroblastic transformation of the synovial membrane and an increase in monocytes constitute a rare but highly characteristic feature of RA. Monocytes synthesize factor (F) XIII, implying that FXIII (a and s) in synovial tissue might help to differentiate between RA and OA. Biopsies were obtained at open surgery from 98 unselected patients with the clinical diagnosis of RA (n = 54) or OA (n = 44). In a three-stage (ABC) immunoperoxidase technique, polyclonal antisera against factor XIIIa and factor XIIIs were investigated. Compared to OA sections. RA synovium showed more FXIIIa-positive cells-monocytes, fibrocytes, fibroblasts and synovial lining cells. In the subsynovial layer, band-like structure of FXIIIa-stained cells was observed in 27.8% of the RA patients, but in only one OA specimen. Higher proportions of FXIIIa-positive monocytes, macrophages, histiocytes and fibroblasts, as well as positive Langhans giant cells and vascular wall regions (except endothelial cells), were observed in RA. OA specimens revealed more intense FXIIIa labeling of these cells with a lower percentage of stained cells. Overall, labeling with FXIIIs antibody resulted in less intense staining. In conclusion, distinction between synovitis caused by RA and synovitis due to OA is possible, as the former show higher numbers of FXIIIa-positive cells, including monocytes, fibroblasts, fibrocytes and synovial lining cells. Further more, RA tissue is stained less intensely than OA tissue. There is evidence for continuous excretion of FXIII in the synovial membrane by the above-mentioned cell systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783420     DOI: 10.1007/bf01419952

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  37 in total

1.  On the Solubility of Fibrin Clots.

Authors:  K Laki; L Lóránd
Journal:  Science       Date:  1948-09-10       Impact factor: 47.728

2.  Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII.

Authors:  J Keski-Oja; D F Mosher; A Vaheri
Journal:  Cell       Date:  1976-09       Impact factor: 41.582

3.  Characterization of synovial macrophages by monoclonal antibodies in rheumatoid arthritis and osteoarthritis.

Authors:  B Helbig; W L Gross; B Borisch; H Starz; H K Müller-Hermelink
Journal:  Scand J Rheumatol Suppl       Date:  1988

4.  [Molecular structure of human fibrin stabilizing factors].

Authors:  H Bohn; H Haupt; T Kranz
Journal:  Blut       Date:  1972-10

5.  Immunohistological demonstration of factors XIIIa and XIIIs in reactive and neoplastic fibroblastic and fibro-histiocytic lesions.

Authors:  M B Reid; C Gray; J D Fear; C C Bird
Journal:  Histopathology       Date:  1986-11       Impact factor: 5.087

6.  Identification of blood coagulation factor XIII in human peritoneal macrophages.

Authors:  R Adány; A Belkin; T Vasilevskaya; L Muszbek
Journal:  Eur J Cell Biol       Date:  1985-07       Impact factor: 4.492

7.  Cross-linking of fibronectin to collagenous proteins.

Authors:  D F Mosher
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

8.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

9.  Incomplete fibrin formation and highly elevated Factor XIII activity in multiple myeloma.

Authors:  H G Klingemann; R Egbring; K Havemann
Journal:  Scand J Haematol       Date:  1981-10

10.  Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII).

Authors:  J Polgár; V Hidasi; L Muszbek
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

View more
  3 in total

Review 1.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

2.  Systemic and intestinal levels of factor XIII-A: the impact of inflammation on expression in macrophage subtypes.

Authors:  Christoffer Soendergaard; Peter Helding Kvist; Jakob Benedict Seidelin; Hermann Pelzer; Ole Haagen Nielsen
Journal:  J Gastroenterol       Date:  2015-12-11       Impact factor: 7.527

3.  Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis.

Authors:  Roberta Gualtierotti; Francesca Ingegnoli; Massimo Boscolo; Samantha Griffini; Elena Grovetti; Massimo Cugno
Journal:  Adv Ther       Date:  2019-10-25       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.